Skip to main content
SpringerLink
Log in

Pankreatitis - ein Überblick

  • Published:
Wiener klinische Wochenschrift Education

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Lankisch PG, Assmus C, Maisonneuve P, Lowenfels AB. Epidemiology of pancreatic diseases in Luneburg County. A study in a defined german population. Pancreatology. 2002;2(5):469–77.

    Article  PubMed  CAS  Google Scholar 

  2. Mofidi R, Duff MD, Wigmore SJ, Madhavan KK, Garden OJ, Parks RW. Association between early systemic inflammatory response, severity of multiorgan dysfunction and death in acute pancreatitis. Br J Surg. 2006 Jun;93(6):738–44.

    Article  PubMed  CAS  Google Scholar 

  3. Mutinga M, Rosenbluth A, Tenner SM, Odze RR, Sica GT, Banks PA. Does mortality occur early or late in acute pancreatitis? Int J Pancreatol. 2000 Oct;28(2):91–5.

    Article  PubMed  CAS  Google Scholar 

  4. Choudari CP, Imperiale TF, Sherman S, Fogel E, Lehman GA. Risk of pancreatitis with mutation of the cystic fibrosis gene. Am J Gastroenterol. [Comparative Study]. 2004 Jul;99(7):1358–63.

    Article  PubMed  CAS  Google Scholar 

  5. Sarles H, Sarles JC, Camatte R, Muratore R, Gaini M, Guien C, et al. Observations on 205 confirmed cases of acute pancreatitis, recurring pancreatitis, and chronic pancreatitis. Gut. 1965 Dec;6(6):545–59.

    Article  PubMed  CAS  Google Scholar 

  6. Seligson U, Cho JW, Ihre T, Lundh G. Clinical course and autopsy findings in acute and chronic pancreatitis. Acta Chir Scand. 1982;148(3):269–74.

    PubMed  CAS  Google Scholar 

  7. Fredrickson DS. An international classification of hyperlipidemias and hyperlipoproteinemias. Ann Intern Med. 1971 Sep;75(3):471–2.

    Article  PubMed  CAS  Google Scholar 

  8. Jacob JJ, John M, Thomas N, Chacko A, Cherian R, Selvan B, et al. Does hyperparathyroidism cause pancreatitis? A South Indian experience and a review of published work. ANZ J Surg. 2006 Aug;76(8):740–4.

    Article  PubMed  Google Scholar 

  9. Carnaille B, Oudar C, Pattou F, Combemale F, Rocha J, Proye C. Pancreatitis and primary hyperparathyroidism: forty cases. Aust N Z J Surg. 1998 Feb;68(2):117–9.

    Article  PubMed  CAS  Google Scholar 

  10. Trivedi CD, Pitchumoni CS. Drug-induced pancreatitis: an update. J Clin Gastroenterol. 2005 Sep;39(8):709–16.

    Article  PubMed  Google Scholar 

  11. Dumonceau JM, Andriulli A, Deviere J, Mariani A, Rigaux J, Baron TH, et al. European Society of Gastrointestinal Endoscopy (ESGE) Guideline: prophylaxis of post-ERCP pancreatitis. Endoscopy. 2010 Jun;42(6):503–15.

    Article  PubMed  Google Scholar 

  12. Elmunzer BJ, Scheiman JM, Lehman GA, Chak A, Mosler P, Higgins PD, et al. A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. N Engl J Med. 2012 Apr 12;366(15):1414–22.

    Article  PubMed  CAS  Google Scholar 

  13. Sofuni A, Maguchi H, Itoi T, Katanuma A, Hisai H, Niido T, et al. Prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis by an endoscopic pancreatic spontaneous dislodgement stent. Clin Gastroenterol Hepatol. 2007 Nov;5(11):1339–46.

    Article  PubMed  Google Scholar 

  14. Forsmark CE, Baillie J. AGA Institute technical review on acute pancreatitis. Gastroenterology. 2007 May;132(5):2022–44.

    Article  PubMed  CAS  Google Scholar 

  15. Blum T, Maisonneuve P, Lowenfels AB, Lankisch PG. Fatal outcome in acute pancreatitis: its occurrence and early prediction. Pancreatology. 2001;1(3):237–41.

    Article  PubMed  CAS  Google Scholar 

  16. Brown A, Orav J, Banks PA. Hemoconcentration is an early marker for organ failure and necrotizing pancreatitis. Pancreas. 2000 May;20(4):367–72.

    Article  PubMed  CAS  Google Scholar 

  17. Eatock FC, Chong P, Menezes N, Murray L, McKay CJ, Carter CR, et al. A randomized study of early nasogastric versus nasojejunal feeding in severe acute pancreatitis. Am J Gastroenterol. 2005 Feb;100(2):432–9.

    Article  PubMed  CAS  Google Scholar 

  18. Isenmann R, Runzi M, Kron M, Kahl S, Kraus D, Jung N, et al. Prophylactic antibiotic treatment in patients with predicted severe acute pancreatitis: a placebo-controlled, double-blind trial. Gastroenterology. 2004 Apr;126(4):997–1004.

    Article  PubMed  CAS  Google Scholar 

  19. Dellinger EP, Tellado JM, Soto NE, Ashley SW, Barie PS, Dugernier T, et al. Early antibiotic treatment for severe acute necrotizing pancreatitis: a randomized, double-blind, placebo-controlled study. Ann Surg. 2007 May;245(5):674–83.

    Article  PubMed  Google Scholar 

  20. Santvoort HC van, Besselink MG, Bakker OJ, Hofker HS, Boermeester MA, Dejong CH, et al. A step-up approach or open necrosectomy for necrotizing pancreatitis. N Engl J Med. 2010 Apr 22;362(16):1491–502.

    Article  PubMed  Google Scholar 

  21. Freeman ML, Werner J, van Santvoort HC, Baron TH, Besselink MG, Windsor JA, et al. Interventions for necrotizing pancreatitis: summary of a multidisciplinary consensus conference. Pancreas. 2012 Nov;41(8):1176–94.

    Article  PubMed  Google Scholar 

  22. Bausch D, Wellner U, Kahl S, Kuesters S, Richter-Schrag HJ, Utzolino S, et al. Minimally invasive operations for acute necrotizing pancreatitis: comparison of minimally invasive retroperitoneal necrosectomy with endoscopic transgastric necrosectomy. Surgery. 2012 Sep;152(3 Nachtrag 1):128–34.

  23. Mullhaupt B, Truninger K, Ammann R. Impact of etiology on the painful early stage of chronic pancreatitis: a long-term prospective study. Z Gastroenterol. 2005 Dec;43(12):1293–301.

    Article  PubMed  CAS  Google Scholar 

  24. Ammann RW, Muellhaupt B. The natural history of pain in alcoholic chronic pancreatitis. Gastroenterology. 1999 May;116(5):1132–40.

    Article  PubMed  CAS  Google Scholar 

  25. Witt H, Apte MV, Keim V, Wilson JS. Chronic pancreatitis: challenges and advances in pathogenesis, genetics, diagnosis, and therapy. Gastroenterology. 2007 Apr;132(4):1557–73.

    Article  PubMed  CAS  Google Scholar 

  26. Rosendahl J, Witt H, Szmola R, Bhatia E, Ozsvari B, Landt O, et al. Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis. Nat Genet. 2008 Jan;40(1):78–82.

    Article  PubMed  CAS  Google Scholar 

  27. Finkelberg DL, Sahani D, Deshpande V, Brugge WR. Autoimmune pancreatitis. N Engl J Med. 2006 Dec 21;355(25):2670–6.

    Article  PubMed  CAS  Google Scholar 

  28. Okazaki K, Chiba T. Autoimmune related pancreatitis. Gut. 2002 Jul;51(1):1–4.

    Article  PubMed  CAS  Google Scholar 

  29. Kamisawa T, Chari ST, Giday SA, Kim MH, Chung JB, Lee KT, et al. Clinical profile of autoimmune pancreatitis and its histological subtypes: an international multicenter survey. Pancreas. 2011 Aug;40(6):809–14.

    Article  PubMed  CAS  Google Scholar 

  30. Chari ST, Kloeppel G, Zhang L, Notohara K, Lerch MM, Shimosegawa T. Histopathologic and clinical subtypes of autoimmune pancreatitis: the honolulu consensus document. Pancreatology. 2010;10(6):664–72.

    Article  PubMed  Google Scholar 

  31. Shimosegawa T, Chari ST, Frulloni L, Kamisawa T, Kawa S, Mino-Kenudson M, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas. 2011 Apr;40(3):352–8.

    Article  PubMed  Google Scholar 

  32. Chari ST, Kloeppel G, Zhang L, Notohara K, Lerch MM, Shimosegawa T. Histopathologic and clinical subtypes of autoimmune pancreatitis: the Honolulu consensus document. Pancreas. 2010 Jul;39(5):549–54.

    Article  PubMed  CAS  Google Scholar 

  33. Graziani R, Frulloni L, Mantovani W, Ambrosetti MC, Mautone S, Re TJ, et al. Autoimmune pancreatitis and non-necrotizing acute pancreatitis: computed tomography pattern. Dig Liver Dis. 2012 Sep;44(9):759–66.

    Article  PubMed  CAS  Google Scholar 

  34. Chari ST. Diagnosis of autoimmune pancreatitis using its five cardinal features: introducing the Mayo Clinic’s HISORt criteria. J Gastroenterol. [Review]. 2007 May;(42 Nachtrag) 18:39–41.

    Article  Google Scholar 

  35. Sandanayake NS, Church NI, Chapman MH, Johnson GJ, Dhar DK, Amin Z, et al. Presentation and management of post-treatment relapse in autoimmune pancreatitis/immunoglobulin G4-associated cholangitis. Clin Gastroenterol Hepatol. 2009 Oct;7(10):1089–96.

    Article  PubMed  CAS  Google Scholar 

  36. Ghazale A, Chari ST, Zhang L, Smyrk TC, Takahashi N, Levy MJ, et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology. 2008 Mar;134(3):706–15.

    Article  PubMed  Google Scholar 

  37. Mendes FD, Jorgensen R, Keach J, Katzmann JA, Smyrk T, Donlinger J, et al. Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis. Am J Gastroenterol. 2006 Sep;101(9):2070–5.

    Article  PubMed  CAS  Google Scholar 

  38. Nakazawa T, Ohara H, Sano H, Ando T, Aoki S, Kobayashi S, et al. Clinical differences between primary sclerosing cholangitis and sclerosing cholangitis with autoimmune pancreatitis. Pancreas. 2005 Jan;30(1):20–5.

    PubMed  Google Scholar 

  39. Nakazawa T, Ohara H, Sano H, Aoki S, Kobayashi S, Okamoto T, et al. Cholangiography can discriminate sclerosing cholangitis with autoimmune pancreatitis from primary sclerosing cholangitis. Gastrointest Endosc. 2004 Dec;60(6):937–44.

    Article  PubMed  Google Scholar 

  40. Kamisawa T, Shimosegawa T, Okazaki K, Nishino T, Watanabe H, Kanno A, et al. Standard steroid treatment for autoimmune pancreatitis. Gut. 2009 Nov;58(11):1504–7.

    Article  PubMed  CAS  Google Scholar 

  41. Hart PA, Topazian MD, Witzig TE, Clain JE, Gleeson FC, Klebig RR, et al. Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. Gut. 2012 Sep 16.

  42. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992 Jun;101(6):1644–55.

  43. Balthazar EJ, Robinson DL, Megibow AJ, Ranson JH. Acutepancreatitis: value of CT in establishing prognosis. Radiology. 1990 Feb;174(2):331–6.

    PubMed  CAS  Google Scholar 

Download references

Interessenkonflikt

Es besteht kein Interessenkonflikt.

Author information

Authors and Affiliations

  1. Klinische Abteilung für Gastroenterologie und Hepatologie, Universitätsklinik für Innere Medizin III, Medizinische Universität Wien, Wien, Österreich

    Katharina Staufer &  Barbara Tribl

Authors
  1. Katharina Staufer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Barbara Tribl
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Barbara Tribl.

Vorbereitungsfragen zur Facharztprüfung

Vorbereitungsfragen zur Facharztprüfung

  1. 1.

    Schwere akute Pankreatitis: Was ist die wichtigste Intervention in den ersten 24 h nach Aufnahme?

  2. a.

    Intravenöse Flüssigkeitszufhr

  3. b.

    Analgetika

  4. c.

    Breitspektrumantibiotika

  5. d.

    Protonenpumpeninhibitor

  6. e.

    Kontrastmittelverstärkter CT

  7. 2.

    Welcher Parameter definiert SIRS nicht?

  8. a.

    Herzfrequenz

  9. b.

    Körpertemperatur

  10. c.

    Serumkalzium

  11. d.

    Leukozytenzahl

  12. e.

    PaO2

  13. 3.

    Akute Pankreatitis: Welcher Parameter bei Aufnahme ist prognostisch irrelevant?

  14. a.

    BMI

  15. b.

    Hämatokrit

  16. c.

    APACHE II

  17. d.

    Alter

  18. e.

    Lipase

  19. 4.

    Welche der folgenden Aussagen ist falsch: Die Entstehung von Sludge in den Gallenwegen wird gefördert durch:

  20. a.

    Parenterale Ernährung

  21. b.

    Therapie mit Ceftriaxon

  22. c.

    Enterale Ernährung

  23. d.

    Langes Fasten

  24. e.

    Distale Gallengangsstenose

  25. 5.

    Antibiotikaprophylaxe bei ödematöser Pankreatitis: Welche Therapie ist indiziert?

  26. a.

    Metronidazol und Ciprofloxazin

  27. b.

    Metronidazol

  28. c.

    keine

  29. d.

    Ciprofloxazin

  30. e.

    Meropenem

  31. 6.

    Welches der angeführten Charakteristika trifft auf die Autoimmunpankreatitis Typ I nicht zu?

  32. a.

    betrifft bevorzugt Männer

  33. b.

    diffuse Schwellung des Pankreas

  34. c.

    fokale Schwellung des Pankreas

  35. d.

    Assoziation mit Sjögren Syndrom

  36. e.

    kein Ansprechen auf Kortikoidtherapie

  37. 7.

    Enzymsubstitution bei chronischer Pankreatitis? Welche Aussage ist richtig?

  38. a.

    10.000 IE Lipase/Mahlzeit, uncoated tablet

  39. b.

    25.000 - 50.000 IE Lipase/Mahlzeit, enteric- coated tablet

  40. c.

    15.000 IE Lipase/Mahlzeit, uncoated tablet plus Protonenpumpenhemmer

  41. d.

    25.000 - 50.000 IE Lipase/Mahlzeit, enteric-coated tablet plus Protonenpumpenhemmer

  42. e.

    10000 IE Lipase/Mahlzeit enteric- coated tablet

  43. 8.

    Pankreasdiät: wie lautet die Empfehlung bei chronischer Pankreatitis?

  44. a.

    Fettarme Kost

  45. b.

    Cholesterinarme Kost

  46. c.

    Es gibt keine Pankreasdiät

  47. d.

    Fettarme, eiweißreduzierte Kost

  48. e.

    Kohlenhydratreduktion

  49. 9.

    Chronische Pankreatitis: welcher der folgenden isolierten Punkte stellt keine Indikation zur ERCP dar:

  50. a.

    Verdacht auf Striktur des Pankreasgangs

  51. b.

    Rezidivierende Schmerzen

  52. c.

    Verdacht auf Pankreasgangsteine

  53. d.

    Steatorrhoe

  54. e.

    Verdacht auf Pankreaspseudozyste

Rights and permissions

Reprints and permissions

About this article

Cite this article

Staufer, K., Tribl, B. Pankreatitis - ein Überblick. Wien. Klin. Wochenschr. Educ 8, 57–72 (2013). https://doi.org/10.1007/s11812-013-0060-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11812-013-0060-8

Search

Navigation